Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Mayank Kumar Sharma"'
Publikováno v:
Mini reviews in medicinal chemistry.
Abstract: Selection of a protein structure is an important step for the success of the drug discovery process using structure-based design. Selection of the right crystal structure is a critical step as multiple crystal structures are available for t
Autor:
Mayank Kumar Sharma, Prashant R. Murumkar, Mange Ram Yadav, Sadhana J. Rajput, Atul N. Khadse
Publikováno v:
Mini-Reviews in Medicinal Chemistry. 18:1332-1353
Development of new anticoagulants has been in constant demand throughout the world due to increasing rate of morbidity and mortality caused by thrombotic diseases. Factor Xa (FXa), one of the enzymes and validated target for anticoagulation, regulate
Publikováno v:
2019 IEEE 5th International Conference for Convergence in Technology (I2CT).
Wireless Sensor Networks [WSN] is formation of sensor nodes deployed in remote areas. It enables sensing of various parameters through wireless network. Low computation and energy consumption with less storage and strong sensing capability has found.
Publikováno v:
Current Topics in Medicinal Chemistry. 16:2863-2883
Nitrogen containing heterocyclic rings with an oxygen atom is considered as one of the best combination in medicinal chemistry due to their diversified biological activities. Isoxazole, a five membered heterocyclic azole ring is found in naturally oc
Autor:
Prashant R. Murumkar, H Yamaguchi, Mange Ram Yadav, A C Shinde, P B Miniyar, Mayank Kumar Sharma
Publikováno v:
SAR and QSAR in Environmental Research. 27:265-292
Type 2 diabetes mellitus is described by insulin resistance and high fasting blood glucose. Increased levels of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme result in insulin resistance and metabolic syndrome. Inhibition of 11β-HSD1 d
Publikováno v:
RSC Advances. 6:1466-1483
Cannabinoid 1 (CB1) receptors are a potential target for the treatment of obesity due to their role in food intake regulation and energy balance. Adverse effects associated with rimonabant, a CB1 receptor antagonist, have encouraged researchers to ma
Autor:
Tushar R. Sutariya, Prashant R. Murumkar, Gaurangkumar C. Brahmbhatt, Narsidas J. Parmar, Irene Lagunes, José M. Padrón, Mayank Kumar Sharma, Mange Ram Yadav, Hitesh A. Barad
Publikováno v:
New Journal of Chemistry. 40:4931-4939
A multicomponent reaction has been developed by incorporating quinoline-3-carbaldehyde, 1,3-cyclohexanedione and 2,3-diaminopyridine into some new quinolylpyrido[2,3-b][1,4]benzodiazepinone assemblies under catalyst- and solvent-free conditions at 12
Publikováno v:
Molecular Diversity. 19:871-893
Peripherally acting cannabinoid 1 (CB1) receptor antagonists are considered as potential therapeutics for the treatment of obesity with desired efficacy and reduced central nervous system side effects. A dataset of 72 compounds containing the 1,5-dia
Autor:
Prashant R. Murumkar, Rajani Giridhar, Mahesh A. Barmade, Mayank Kumar Sharma, Mange Ram Yadav
Publikováno v:
Expert Opinion on Therapeutic Patents. 25:1093-1116
Introduction: Obesity is a rapidly expanding worldwide health problem. Various targets are investigated presently for the treatment of obesity, but there remains an unmet need for an effective drug therapy with acceptable efficacy levels and reduced
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-18 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-18 (2018)
Developing peripherally active cannabinoid 1 (CB1) receptor antagonists is a novel therapeutic approach for the management of obesity. An unusual phenothiazine scaffold containing CB1R antagonizing hit was identified by adopting virtual screening wor